Erector Spinae Plane Block Versus Caudal Epidural Analgesia
NCT ID: NCT06815094
Last Updated: 2025-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
32 participants
INTERVENTIONAL
2022-11-28
2024-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Which of them has a superior analgesic effect.
* which of them is more safe and has less complication rate. Participants or their guardians should agree to share in the study (after full explanation of risks and benefits) to receive one of the previously mentioned regional blocks in conjunction with the classic balanced general anaesthesia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae Block Versus Caudal Block for Perioperative Analgesia in Pediatric Cancer Patients
NCT05153720
Analgesic Efficacy of Erector Spinae Plane Block vs External Oblique Intercostal Plane Block in Subcostal Cancer Surgeries
NCT06519708
Ultrasound-guided Continuous Erector Spinae Plane Block Versus Thoracic Epidural Analgesia in Open Nephrectomy
NCT04947644
Lumbar Epidural Analgesia With Bilateral Erector Spinae Block for Pain Management in Lumbar Spine Surgery
NCT04320212
Ultrasound Guided Erector Spinae Plane Block vs External Oblique Intercostal Plane Block for Nephrectomy
NCT06048744
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group of patients received Caudal Epidural Analgesia
Pediatric patients aged 8 to 15 years of age undergoing unilateral lower limb cancer surgery are recruited from National Cancer Institute \& randomly allocated to this group.
Regional analgesia either CEA or ESP
Ultrasound guided local anesthetic injection in the course of the conducting nerve to decrease pain transmission.
Group of patients received Erector Spinae Plane block
Pediatric patients aged 8 to 15 years of age undergoing unilateral lower limb cancer surgery are recruited from National Cancer Institute \& randomly allocated to this group.
Regional analgesia either CEA or ESP
Ultrasound guided local anesthetic injection in the course of the conducting nerve to decrease pain transmission.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Regional analgesia either CEA or ESP
Ultrasound guided local anesthetic injection in the course of the conducting nerve to decrease pain transmission.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 8 - 15 years of age.
* Planned to undergo unilateral lower limb cancer surgery.
Exclusion Criteria
* History of allergy to local anaesthetics or any of the additives.
* Patients refused to be included in the study or their guardians.
* CNS (Central Nervous System) pathology.
* Unstable cardiovascular disease.
* Local or systemic infection.
8 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Atef Badran, MD
Role: STUDY_DIRECTOR
National cancer institute - Cairo university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute
Cairo, ELkhalig, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP2211-301-044
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.